These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Study of pro-inflammatory (TNF-alpha, IL-1alpha, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters. Kutukculer N; Caglayan S; Aydogdu F Clin Rheumatol; 1998; 17(4):288-92. PubMed ID: 9776110 [TBL] [Abstract][Full Text] [Related]
3. Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis. Gattorno M; Picco P; Buoncompagni A; Stalla F; Facchetti P; Sormani MP; Pistoia V Ann Rheum Dis; 1996 Apr; 55(4):243-7. PubMed ID: 8733441 [TBL] [Abstract][Full Text] [Related]
4. Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis. De Benedetti F; Robbioni P; Massa M; Viola S; Albani S; Martini A Clin Exp Rheumatol; 1992; 10(5):493-8. PubMed ID: 1458703 [TBL] [Abstract][Full Text] [Related]
5. Inflammatory cytokine responses in juvenile chronic arthritis. Rooney M; David J; Symons J; Di Giovine F; Varsani H; Woo P Br J Rheumatol; 1995 May; 34(5):454-60. PubMed ID: 7788176 [TBL] [Abstract][Full Text] [Related]
6. Circulating levels of interleukin 1 beta and of interleukin 1 receptor antagonist in systemic juvenile chronic arthritis. De Benedetti F; Pignatti P; Massa M; Sartirana P; Ravelli A; Martini A Clin Exp Rheumatol; 1995; 13(6):779-84. PubMed ID: 8835254 [TBL] [Abstract][Full Text] [Related]
7. Cytokine levels in serum of patients with juvenile rheumatoid arthritis. Yilmaz M; Kendirli SG; Altintas D; Bingöl G; Antmen B Clin Rheumatol; 2001; 20(1):30-5. PubMed ID: 11254238 [TBL] [Abstract][Full Text] [Related]
8. Circulating interleukin-6, soluble interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-10 levels in juvenile chronic arthritis: correlations with soft tissue vascularity assessed by power Doppler sonography. Shahin AA; Shaker OG; Kamal N; Hafez HA; Gaber W; Shahin HA Rheumatol Int; 2002 Jun; 22(2):84-8. PubMed ID: 12070682 [TBL] [Abstract][Full Text] [Related]
9. Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis. Lepore L; Pennesi M; Saletta S; Perticarari S; Presani G; Prodan M Clin Exp Rheumatol; 1994; 12(5):561-5. PubMed ID: 7531125 [TBL] [Abstract][Full Text] [Related]
11. Association between serum inflammatory cytokines and disease activity in juvenile idiopathic arthritis. Ou LS; See LC; Wu CJ; Kao CC; Lin YL; Huang JL Clin Rheumatol; 2002 Feb; 21(1):52-6. PubMed ID: 11954886 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor. Peake NJ; Khawaja K; Myers A; Nowell MA; Jones SA; Rowan AD; Cawston TE; Foster HE Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760 [TBL] [Abstract][Full Text] [Related]
13. Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-alpha (cA2). Elliott MJ; Woo P; Charles P; Long-Fox A; Woody JN; Maini RN Br J Rheumatol; 1997 May; 36(5):589-93. PubMed ID: 9189062 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis. Jelusić M; Lukić IK; Tambić-Bukovac L; Dubravcić K; Malcić I; Rudan I; Batinić D Clin Rheumatol; 2007 Aug; 26(8):1332-4. PubMed ID: 17597334 [TBL] [Abstract][Full Text] [Related]
15. Using the Juvenile Arthritis Disease Activity Score based on erythrocyte sedimentation rate or C-reactive protein level: results from the Portuguese register. Mourão AF; Santos MJ; Melo-Gomes J; Martins FM; Costa JA; Ramos F; Brito I; Duarte C; Figueira R; Figueiredo G; Furtado C; Lopes A; Oliveira M; Rodrigues A; Salgado M; Sousa M; Branco JC; Fonseca JE; Canhão H Arthritis Care Res (Hoboken); 2014 Apr; 66(4):585-91. PubMed ID: 25354266 [TBL] [Abstract][Full Text] [Related]
16. Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate. Xiao Y; Haynes WL; Michalek JE; Russell IJ Rheumatol Int; 2013 May; 33(5):1259-64. PubMed ID: 23124693 [TBL] [Abstract][Full Text] [Related]
17. Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs. Straub RH; Müller-Ladner U; Lichtinger T; Schölmerich J; Menninger H; Lang B Br J Rheumatol; 1997 Dec; 36(12):1298-303. PubMed ID: 9448591 [TBL] [Abstract][Full Text] [Related]
18. Multiple inhibitors of mitogen-induced proliferation of normal lymphocytes in juvenile chronic arthritis sera. De Benedetti F; Marconi M; Ravelli A; Goggi D; Maccario R; Viola S; Martini A Clin Exp Rheumatol; 1990; 8(5):505-11. PubMed ID: 2124529 [TBL] [Abstract][Full Text] [Related]
19. Lymphokines and soluble interleukin-2 receptors in juvenile chronic arthritis. Clinical and laboratory correlations. Müller K; Pedersen FK; Wiik A; Bendtzen K Rheumatol Int; 1992; 12(3):89-92. PubMed ID: 1411093 [TBL] [Abstract][Full Text] [Related]